Company performance
Add to research
Current Price
as of Feb 13, 2025$870.36
P/E Ratio
74.43
Market Cap
$827.67B
Description
Add to research
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Metrics
Add to research
Overview
- HQIndianapolis, IN
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerLLY
- Price$870.36-0.13%
Trading Information
- Market cap$827.67B
- Float89.62%
- Average Daily Volume (1m)3,692,926
- Average Daily Volume (3m)3,840,258
- EPSN/A
Company
- Revenue$45.04B
- Rev growth (1yr)32.00%
- Net income$10.59B
- Gross margin82.54%
- EBITDA marginN/A
- EBITDAN/A
- EVN/A
- EV/RevenueN/A
- P/E74.43
- P/S17.50
- P/B58.18
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account
Wikipedia